RENAPIME Powder for solution for injection / infusion Ref.[6584] Active ingredients: Cefepime

Source: Medicines & Healthcare Products Regulatory Agency (GB)  Revision Year: 2017  Publisher: Renascience Pharma Ltd, 11 George Street West, Luton, Bedfordshire, LU1 2BJ, United Kingdom

Product name and form

Renapime 1 g powder for solution for injection/infusion.


Pharmaceutical Form

Powder for solution for injection/infusion.

White to pale yellow powder.

Qualitative and quantitative composition

Renapime 1 g powder for solution for injection or infusion: One vial contains 1 g of cefepime (as dihydrochloride monohydrate).


For the full list of excipients, see section 6.1.

Active Ingredient Description

Cefepime is a broad-spectrum, bactericidal antibiotic, with activity against a wide range of Gram-positive and Gram-negative bacteria, including many strains resistant to aminoglycosides or third generation cephalosporins. It has a reduced affinity for beta-lactamases.

List of Excipients


Pack sizes and marketing

Colourless type II 20 ml glass vial closed with chlorobutyl rubber stopper and sealed with an aluminium cap and a plastic flip-off.

Pack size: 1, 5, 10, 20, 25, 50 and 100 vials.

Not all pack sizes may be marketed.

Marketing authorization holder

Renascience Pharma Ltd, 11 George Street West, Luton, Bedfordshire, LU1 2BJ, United Kingdom

Marketing authorization dates and numbers

PL 44696/0001



Drug Countries
RENAPIME Estonia, United Kingdom

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.